GENNIEFY
Market News
Latest financial news and analysis from global markets
NVDA
Nvidia Could Be the First $22 Trillion Stock, According to 1 Top Analyst. But There's a Big Catch.
A key assumption in UBS' valuation model for Nvidia may not hold up.
INTC
Nvidia Could Be the First $22 Trillion Stock, According to 1 Top Analyst. But There's a Big Catch.
A key assumption in UBS' valuation model for Nvidia may not hold up.
INTC
One of Greg Abel's Forever Holdings at Berkshire Hathaway Is Breaking Warren Buffett's Most Important Investing Rule
The Oracle of Omaha was always unwavering when it came to value and getting a good deal.
NVDA
One of Greg Abel's Forever Holdings at Berkshire Hathaway Is Breaking Warren Buffett's Most Important Investing Rule
The Oracle of Omaha was always unwavering when it came to value and getting a good deal.
AAPL
One of Greg Abel's Forever Holdings at Berkshire Hathaway Is Breaking Warren Buffett's Most Important Investing Rule
The Oracle of Omaha was always unwavering when it came to value and getting a good deal.
JNJ
Earnings Season Ramps Up: What to Watch for the Rest of the Week
JPMorgan Chase highlights a busy bank earnings season as investors watch for impacts of the Iran war and concerns about a potential private-credit meltdown. Netflix and Johnson & Johnson are also on deck to report.
LULU
Lululemon faces Texas probe over PFAS in products
The CID is part of a broader inquiry into whether the company may have misled consumers about the safety, quality and health implications of its merchandise.
USD/CHF
Euro’s Gains Could Prove Limited For Now
The euro rose to a six-week high against a weaker dollar but is unlikely to rise much further even if the ECB President reiterates that interest-rate rises are possible, ING said.
EUR/USD
Euro’s Gains Could Prove Limited For Now
The euro rose to a six-week high against a weaker dollar but is unlikely to rise much further even if the ECB President reiterates that interest-rate rises are possible, ING said.
MRK
How Merck keeps prices for its blockbuster cancer drug sky high
Merck built a wall of patents to keep a cancer drug's price – and its profits – high. Hospitals often add to the cost for American patients.
NKE
Nike Leadership Change Puts Focus On Product Reset And Investor Confidence
Nike’s Chief Innovation Officer Tom Bignall has departed less than a year after his promotion. This is the fourth leadership change in this role in three years, focusing attention on Nike’s product and innovation teams. The exit comes as investors watch for signs of progress in Nike’s product pipeline and brand refresh efforts. Nike, NYSE:NKE, is contending with another leadership change just as its share price sits at $42.91 and recent returns have been weak. The stock shows a 20.5%...
LMT
Lockheed Martin’s PAC-3 And Artemis II Milestones Shape LMT Valuation Insight
Lockheed Martin secured a $4.76b contract to produce PAC-3 MSE interceptors, expanding its missile production backlog. The company completed NASA's Artemis II mission with a successful crewed splashdown of the Orion spacecraft. These developments reinforce Lockheed Martin's role in both defense systems and human spaceflight programs. For investors watching NYSE:LMT, these announcements come alongside strong recent share performance, with the stock up 24.7% year to date and 33.9% over the...